Deep Track Capital, LP Portfolio Holdings

Deep Track Capital, LP

  • $2.27 Billion
  • Q4 2024

Deep Track Capital, LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $2.27 Billion distributed in 63 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Dynavax Technologies Corp with a value of $227M, Guardant Health, Inc. with a value of $196M, Intra Cellular Therapies, Inc. with a value of $167M, Immunovant, Inc. with a value of $165M, and Apellis Pharmaceuticals, Inc. with a value of $136M.

Examining the 13F form we can see an decrease of $442M in the current position value, from $2.71B to 2.27B.

Deep Track Capital, LP is based out at Greenwich, CT

Below you can find more details about Deep Track Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $2.27 Billion
Healthcare: $2.27 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.73B
$227 Million 10.01% of portfolio
17,791,486
Q4 2024 Added 42.03%
$4.73B
$196 Million 8.64% of portfolio
6,419,566
Q4 2024 Added 6.98%
$12.4B
$167 Million 7.36% of portfolio
2,000,000
Q4 2024 Added 24.95%
$3.55B
$165 Million 7.27% of portfolio
6,000,000
Q4 2024 Added 38.01%
$2.73B
$136 Million 6.01% of portfolio
4,274,921
Q4 2024 Reduced 2.86%
$3.16B
$125 Million 5.51% of portfolio
3,460,756
Q4 2024 Reduced 9.97%
$4.09B
$118 Million 5.18% of portfolio
2,500,000
Q4 2024 Added 296.88%
$593M
$110 Million 4.83% of portfolio
12,836,282
Q4 2024 Added 0.9%
$604M
$86.7 Million 3.82% of portfolio
4,522,741
Q4 2024 Added 20.58%
$82.3M
$78.7 Million 3.46% of portfolio
5,972,257
Q2 2024 Added 3.87%
$4.73B
$67.6 Million 2.98% of portfolio
1,933,928
Q4 2024 Reduced 12.09%
$655M
$56.5 Million 2.49% of portfolio
3,000,000
Q4 2024 Reduced 22.44%
$2.04B
$49.9 Million 2.2% of portfolio
1,450,000
Q4 2024 New
$391M
$49.7 Million 2.19% of portfolio
6,478,249
Q4 2024 Added 134.17%
$642M
$47.1 Million 2.08% of portfolio
2,000,000
Q4 2024 Reduced 39.06%
$13.3B
$41.7 Million 1.84% of portfolio
2,000,000
Q4 2024 New
$3.87B
$39.5 Million 1.74% of portfolio
850,000
Q4 2024 Reduced 73.27%
$933M
$38.9 Million 1.71% of portfolio
1,540,132
Q4 2024 New
$2.67B
$38.6 Million 1.7% of portfolio
1,000,000
Q4 2024 New
$1.13B
$35.9 Million 1.58% of portfolio
649,042
Q4 2024 Added 28.57%
$505M
$35.4 Million 1.56% of portfolio
10,689,603
Q4 2024 Reduced 2.41%
$163M
$33.4 Million 1.47% of portfolio
14,218,903
Q4 2024 Reduced 6.9%
$120M
$31.1 Million 1.37% of portfolio
5,576,558
Q3 2024 Reduced 8.58%
$2.78B
$27.5 Million 1.21% of portfolio
653,513
Q4 2024 New
$1.58B
$22.6 Million 1.0% of portfolio
1,350,000
Q3 2024 New
$5B
$22.5 Million 0.99% of portfolio
819,162
Q4 2024 New
$1.72B
$21.5 Million 0.95% of portfolio
780,778
Q4 2024 New
$179M
$20.1 Million 0.88% of portfolio
3,442,833
Q4 2024 Reduced 13.93%
$1.55B
$19 Million 0.84% of portfolio
710,421
Q4 2024 Reduced 35.45%
$283M
$17.9 Million 0.79% of portfolio
1,276,081
Q4 2024 Reduced 64.03%
$619M
$16.1 Million 0.71% of portfolio
2,000,000
Q4 2024 New
$1.26B
$15.3 Million 0.67% of portfolio
519,376
Q4 2024 New
$642M
$14.2 Million 0.63% of portfolio
4,011,287
Q4 2024 Reduced 47.05%
$784M
$11.5 Million 0.51% of portfolio
500,000
Q4 2024 Reduced 37.5%
$34.1M
$9.5 Million 0.42% of portfolio
6,011,380
Q4 2024 New
$12.8M
$7.35 Million 0.32% of portfolio
7,419,355
Q2 2024 New
$22M
$6.9 Million 0.3% of portfolio
5,704,282
Q4 2024 Added 14.09%
$2.18B
$6.63 Million 0.29% of portfolio
169,132
Q4 2024 New
$20.5M
$5.15 Million 0.23% of portfolio
3,262,564
Q2 2024 Reduced 0.12%
$109M
$4.27 Million 0.19% of portfolio
1,040,115
Q4 2024 Reduced 52.05%
$124M
$3.4 Million 0.15% of portfolio
609,900
Q4 2024 Reduced 85.11%
$169M
$1.84 Million 0.08% of portfolio
1,975,998
Q4 2024 Reduced 87.59%
Abivax Sa
-
$0 0.0% of portfolio
-
Q3 2024 Reduced 14.37%
Spyre Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 78.1%
Aligos Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2024 New
Avalo Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 10.34%
Upstream Bio Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 129.41%
Septerna Inc
-
$0 0.0% of portfolio
-
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 63
  • Current Value $2.27 Billion
  • Prior Value $2.71 Billion
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 14 stocks
  • Additional Purchases 17 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 20 stocks
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email